Roberta Mussinelli

7PUBLICATIONS
83CO-AUTHORS
Bioinformatic methods developmentCardiology (incl. cardiovascular diseases)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 07, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System.

Jahanzaib Khwaja, Amy A Kirkwood, Paolo Milani

|May 15, 2025
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy.

Laura De Michieli, Giulio Sinigiani, Gianluigi Guida

|Dec 24, 2024
Predictors of Early Death in Patients With Wild-Type Transthyretin Cardiac Amyloidosis.

Paolo Milani, Giuseppe Damiano Sanna, Roberta Mussinelli

|Aug 01, 2024
Correction to: Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy.

Luca Gentile, Anna Mazzeo, Chiara Briani

|Apr 15, 2024
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy.

Luca Gentile, Anna Mazzeo, Chiara Briani

|Mar 21, 2024
Development and Validation of Staging Systems for AA Amyloidosis.

Marco Basset, Stefan O Schönland, Laura Obici

Pageof 2